Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Astera Labs Inc’s stock clocked out at $168.25, down -1.19% from its previous closing price of $170.28. In other words, the price has decreased by -$1.19 from its previous closing price. On the day, 2.92 million shares were traded. ALAB stock price reached its highest trading level at $174.93 during the session, while it also had its lowest trading level at $166.7304.
Ratios:
To gain a deeper understanding of ALAB’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 132.94. For the most recent quarter (mrq), Quick Ratio is recorded 10.55 and its Current Ratio is at 11.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On October 03, 2025, BofA Securities started tracking the stock assigning a Neutral rating and target price of $230.
On October 01, 2025, TD Cowen started tracking the stock assigning a Hold rating and target price of $200.TD Cowen initiated its Hold rating on October 01, 2025, with a $200 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 01 ’25 when Mazzara Philip sold 10,000 shares for $192.16 per share. The transaction valued at 1,921,572 led to the insider holds 151,573 shares of the business.
ALBA MANUEL sold 183,000 shares of ALAB for $31,707,713 on Sep 02 ’25. The Director now owns 385,863 shares after completing the transaction at $173.27 per share. On Aug 28 ’25, another insider, Mazzara Philip, who serves as the General Counsel and Secretary of the company, sold 10,000 shares for $188.70 each. As a result, the insider received 1,886,956 and left with 161,573 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 27966369792 and an Enterprise Value of 26933590016. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 295.02, and their Forward P/E ratio for the next fiscal year is 79.98. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 46.18 while its Price-to-Book (P/B) ratio in mrq is 24.62. Its current Enterprise Value per Revenue stands at 44.478 whereas that against EBITDA is 577.392.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.28, which has changed by 1.3167348 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is -14.24%, while the 200-Day Moving Average is calculated to be 41.21%.
Shares Statistics:
It appears that ALAB traded 6.25M shares on average per day over the past three months and 6653970 shares per day over the past ten days. A total of 166.21M shares are outstanding, with a floating share count of 130.24M. Insiders hold about 21.64% of the company’s shares, while institutions hold 61.97% stake in the company. Shares short for ALAB as of 1760486400 were 9260453 with a Short Ratio of 1.48, compared to 1757894400 on 9621313. Therefore, it implies a Short% of Shares Outstanding of 9260453 and a Short% of Float of 7.580000000000001.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 15.0 analysts currently analyzing and rating the stock of Astera Labs Inc (ALAB).The consensus estimate for the next quarter is $0.42, with high estimates of $0.46 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.62 and $1.55 for the fiscal current year, implying an average EPS of $1.58. EPS for the following year is $2.09, with 17.0 analysts recommending between $2.88 and $1.8.
Revenue Estimates
In. The current quarter, 14 analysts expect revenue to total $206.42M. It ranges from a high estimate of $208.1M to a low estimate of $201.52M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $113.09MFor the next quarter, 14 analysts are estimating revenue of $216.49M. There is a high estimate of $222.3M for the next quarter, whereas the lowest estimate is $209.58M.
A total of 17 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $805M, while the lowest revenue estimate was $762.47M, resulting in an average revenue estimate of $776.46M. In the same quarter a year ago, actual revenue was $396.29MBased on 16 analysts’ estimates, the company’s revenue will be $1.04B in the next fiscal year. The high estimate is $1.29B and the low estimate is $972.5M.
